Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to do an analysis on UPS stock, UNP stock and ISRG stock.

2 extracted signals · 2 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
13 Dec 2025, 21:10 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Friends! In this video, I'm going to do an analysis on UPS stock, UNP stock and ISRG stock.
Source overview

AI-generated source summary

The analysis covers two stocks, ADBE and MSCI, with a focus on their financial performance and market positioning. ADBE is presented as a high-quality company that has been underperforming but shows strong fundamentals, particularly in AI-influenced revenue, suggesting potential for recovery despite current valuation concerns. MSCI is also identified as a solid company with a strong recurring revenue model and excellent execution, but its stock is considered overvalued after a period of stagnation, potentially leading to future contraction. The speaker highlights the importance of valuation multiples and long-term contracts in assessing these companies' future prospects, with a general outlook leaning towards bullishness for both, contingent on market conditions and company-specific growth drivers.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
2
Extracted from this source
Open
0
Still being tracked
Successful
1
Resolved successfully
Failed
1
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
50%
2 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    2 eligible signals linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.2
Tracked signals
327
Historical success
33.8%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail